DPP4 and obesity disorder: In addition, the study found that the genetic disruption of hepatocyte DPP4 resulted in abrogation of obesity-associated increase of plasma DPP4 activity, repression of liver cytokine expression, and partly amelioration of inflammation in adipose tissue, however the incretin levels and glucose homeostasis were not affected [15].